To verify the cytotoxicity efficacy of FLT3L CAR-T cells to primary AML cells, we co-cultured FLT3L CAR-T cells with primary AML cells from 10 patients (Table 1), including 5 FLT3-ITD patients (nos. This evidence concerns the gene FLT3LG and acute myeloid leukemia.